Scott Braunstein - 21 Jun 2025 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role: Director
Signature: /s/ Rodney Young, Attorney-in-Fact
Issuer symbol: RAPT
Transactions as of: 21 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 24 Jun 2025, 16:25:28 UTC
Previous filing: 21 Feb 2025
Next filing: 27 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Braunstein Scott	Director	C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE, SOUTH SAN FRANCISCO	/s/ Rodney Young, Attorney-in-Fact	24 Jun 2025	0001643875

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RAPT	Director Stock Option (right to buy)	Award	$0	+25,000		$0.000000	25,000	21 Jun 2025	Common Stock	25,000	$7.43	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall vest in three successive equal annual installments over the three-year period measured from the date of grant of June 21, 2025.